122 related articles for article (PubMed ID: 16466094)
1. Can Ki-67 predict recurrence of NO squamous cell carcinoma of the tongue?
Davies L; Hardin NJ; Beatty BG
Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):12-7. PubMed ID: 16466094
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue.
Kim SJ; Shin HJ; Jung KY; Baek SK; Shin BK; Choi J; Kim BS; Shin SW; Kim YH; Kim JS; Oosterwijk E
Jpn J Clin Oncol; 2007 Nov; 37(11):812-9. PubMed ID: 18057013
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of EGFR and hyaluronan in tongue cancer and the development of regional recurrence in patients initially diagnosed N0.
Lindell Jonsson E; Nylander K; Hallén L; Laurell G
Acta Otolaryngol; 2017 Aug; 137(8):877-882. PubMed ID: 28355940
[TBL] [Abstract][Full Text] [Related]
4. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
[TBL] [Abstract][Full Text] [Related]
5. CD147 and Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of oral tongue: a tissue microarray study.
Yu YH; Morales J; Feng L; Lee JJ; El-Naggar AK; Vigneswaran N
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 May; 119(5):553-65. PubMed ID: 25747176
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinoma.
Cordes C; Münzel AK; Rudolph P; Hoffmann M; Leuschner I; Gottschlich S
Anticancer Res; 2009 Apr; 29(4):1459-65. PubMed ID: 19414402
[TBL] [Abstract][Full Text] [Related]
7. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
8. [Squamous-cell carcinoma of the tongue: treatment results and prognosis].
Zwetyenga N; Majoufre-Lefebvre C; Siberchicot F; Demeaux H; Pinsolle J
Rev Stomatol Chir Maxillofac; 2003 Feb; 104(1):10-7. PubMed ID: 12644785
[TBL] [Abstract][Full Text] [Related]
9. ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: correlation with clinical outcomes.
Silva SD; Perez DE; Alves FA; Nishimoto IN; Pinto CA; Kowalski LP; Graner E
Oral Oncol; 2008 May; 44(5):484-90. PubMed ID: 17825601
[TBL] [Abstract][Full Text] [Related]
10. Proliferative index activity in oral squamous cell carcinoma: indication for postoperative radiotherapy?
Gontarz M; Wyszyńska-Pawelec G; Zapała J; Czopek J; Lazar A; Tomaszewska R
Int J Oral Maxillofac Surg; 2014 Oct; 43(10):1189-94. PubMed ID: 24814691
[TBL] [Abstract][Full Text] [Related]
11. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL
Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue.
Kauppila JH; Mattila AE; Karttunen TJ; Salo T
Br J Cancer; 2013 Feb; 108(3):638-43. PubMed ID: 23287987
[TBL] [Abstract][Full Text] [Related]
13. Gene expression changes in tumor free tongue tissue adjacent to tongue squamous cell carcinoma.
Boldrup L; Gu X; Coates PJ; Norberg-Spaak L; Fahraeus R; Laurell G; Wilms T; Nylander K
Oncotarget; 2017 Mar; 8(12):19389-19402. PubMed ID: 28038473
[TBL] [Abstract][Full Text] [Related]
14. Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue.
Häyry V; Mäkinen LK; Atula T; Sariola H; Mäkitie A; Leivo I; Keski-Säntti H; Lundin J; Haglund C; Hagström J
Br J Cancer; 2010 Mar; 102(5):892-7. PubMed ID: 20145620
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 and Ki-67 expression correlates to tumor staging in tongue squamous cell carcinoma.
Guimarães EP; de Carli ML; Sperandio FF; Hanemann JA; Pereira AA
Med Oral Patol Oral Cir Bucal; 2015 Nov; 20(6):e657-63. PubMed ID: 26449430
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Nguyen TV; Bova RJ; Kench JG; Cole IE; Musgrove EA; Henshall SM; Sutherland RL
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3705-11. PubMed ID: 14506162
[TBL] [Abstract][Full Text] [Related]
17. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
18. Lymphangiogenesis in regional lymph nodes predicts nodal recurrence in pathological N0 squamous cell carcinoma of the tongue.
Hirota K; Wakisaka N; Sawada-Kitamura S; Kondo S; Endo K; Tsuji A; Murono S; Yoshizaki T
Histopathology; 2012 Dec; 61(6):1065-71. PubMed ID: 22957497
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma of the oral tongue in patients younger than 30 years: comparison with patients older than 60 years.
Hilly O; Shkedy Y; Hod R; Soudry E; Mizrachi A; Hamzany Y; Bachar G; Shpitzer T
Oral Oncol; 2013 Oct; 49(10):987-90. PubMed ID: 23927849
[TBL] [Abstract][Full Text] [Related]
20. Survivin expression correlates with nodal metastasis in T1-T2 squamous cell carcinoma of the tongue.
Doğan M; Çağlı S; Yüce İ; Bayram A; Somdaş MA; Karataş D; Cihan MC; Yüksel F; Güney E
Eur Arch Otorhinolaryngol; 2015 Mar; 272(3):689-94. PubMed ID: 24676727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
